{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:10:21Z","timestamp":1781316621010,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["21K08469"],"award-info":[{"award-number":["21K08469"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-021-05066-0","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:03:06Z","timestamp":1641859386000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u201cCoexistence of IgA nephropathy and renal artery stenosis in Takayasu arteritis: case report and literature review\u201d"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-7976","authenticated-orcid":false,"given":"Nono","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-3514","authenticated-orcid":false,"given":"Tsuyoshi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-3005","authenticated-orcid":false,"given":"Takafumi","family":"Toyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5694-5236","authenticated-orcid":false,"given":"Hideaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-7792","authenticated-orcid":false,"given":"Hiroko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-6492","authenticated-orcid":false,"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5361-5824","authenticated-orcid":false,"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-7442","authenticated-orcid":false,"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"5066_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41232-020-00119-6","volume":"40","author":"H Yoshifuji","year":"2020","unstructured":"Yoshifuji H, Terao C (2020) Roles of cytotoxic lymphocytes and MIC\/LILR families in pathophysiology of Takayasu arteritis. Inflamm Regener 40:9. https:\/\/doi.org\/10.1186\/s41232-020-00119-6","journal-title":"Inflamm Regener"},{"key":"5066_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/s41467-020-15088-0","volume":"11","author":"T Mutoh","year":"2020","unstructured":"Mutoh T, Shirai T, Ishii T, Shirota Y, Fujishima F, Takahashi F, Kakuta Y, Kanazawa Y, Masamune A, Saiki Y, Harigae H, Fujii H (2020) Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis. Nat Commun 11:1253. https:\/\/doi.org\/10.1038\/s41467-020-15088-0","journal-title":"Nat Commun"},{"key":"5066_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2013.854045","volume":"24","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Ishii T, Nakamura K, Shirai T, Fujii H, Saito S, Harigae H (2014) Ulcerative colitis is not a rare complication of Takayasu arteritis. Mod Rheumatol 24:372\u2013373. https:\/\/doi.org\/10.3109\/14397595.2013.854045","journal-title":"Mod Rheumatol"},{"key":"5066_CR4","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/rheumatology\/keaa019","volume":"59","author":"T Shirai","year":"2020","unstructured":"Shirai T, Murakami K, Fujii H, Ishii T, Harigae H (2020) Comment on: Aortarctia: a rare manifestation of relapsing polychondritis. Rheumatology (Oxford) 59:1784\u20131785. https:\/\/doi.org\/10.1093\/rheumatology\/keaa019","journal-title":"Rheumatology (Oxford)"},{"key":"5066_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s41927-019-0098-z","volume":"3","author":"X Zhang","year":"2019","unstructured":"Zhang X, Jiao Y (2019) Takayasu arteritis with pyoderma gangrenosum: case reports and literature review. BMC Rheumatol 3:45. https:\/\/doi.org\/10.1186\/s41927-019-0098-z","journal-title":"BMC Rheumatol"},{"key":"5066_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2169\/internalmedicine.0329-17","volume":"57","author":"T Shirai","year":"2018","unstructured":"Shirai T, Hanaoka R, Goto Y, Kojima I, Ishii Y, Hoshi Y, Fujita Y, Shirota Y, Fujii H, Ishii T, Harigae H (2018) Takayasu Arteritis coexisting with sclerosing osteomyelitis. Intern Med 57:1929\u20131934. https:\/\/doi.org\/10.2169\/internalmedicine.0329-17","journal-title":"Intern Med"},{"key":"5066_CR7","first-page":"10","volume":"25","author":"P de Pablo","year":"2007","unstructured":"de Pablo P, Garc\u00eda-Torres R, Uribe N, Ram\u00f3n G, Nava A, Silveira LH, Amezcua-Guerra LM, Mart\u00ednez-Lav\u00edn M, Pineda C (2007) Kidney involvement in Takayasu arteritis. Clin Exp Rheumatol 25:10\u201314","journal-title":"Clin Exp Rheumatol"},{"key":"5066_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"S0272\u20136386","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN (2021) IgA Nephropathy: core curriculum 2021. Am J Kidney S0272\u20136386:598\u2013599. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.024","journal-title":"Am J Kidney"},{"key":"5066_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.kint.2018.02.030","volume":"94","author":"MK Saha","year":"2018","unstructured":"Saha MK, Julian BA, Novak J, Rizk DV (2018) Secondary IgA nephropathy. Kidney Int 94:674\u2013681. https:\/\/doi.org\/10.1016\/j.kint.2018.02.030","journal-title":"Kidney Int"},{"key":"5066_CR10","first-page":"273","volume":"35","author":"H Ito","year":"1993","unstructured":"Ito H (1993) HLA haplotypes associated with IgA nephropathy. Jpn J Nephrol 35:273\u2013280 (Japanese)","journal-title":"Jpn J Nephrol"},{"key":"5066_CR11","first-page":"442","volume":"5","author":"M Endo","year":"2008","unstructured":"Endo M (2008) The Epidemiology, symptoms, and prognosis of IgA nephropathy. Jpn J Nephrol 5:442\u2013447 (Japanese)","journal-title":"Jpn J Nephrol"},{"key":"5066_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I (2018) Epidemiology of IgA nephropathy: a global perspective. Semin Nephrol 38:435\u2013442. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.013","journal-title":"Semin Nephrol"},{"key":"5066_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"IS Roberts","year":"2009","unstructured":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D\u2019Agati V, D\u2019Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546\u2013556. https:\/\/doi.org\/10.1038\/ki.2009.168","journal-title":"Kidney Int"},{"key":"5066_CR14","unstructured":"Yamagishi T (1980) A case of aortitis syndrome complicated with IgA nephropathy. Jpn J Nephrol 22:1671 (Japanese)"},{"key":"5066_CR15","unstructured":"Suzuki T (1981) A case of IgA nephropathy complicated with aortitis syndrome. Jpn J Nephrol 23:1624 (Japanese)"},{"key":"5066_CR16","first-page":"937","volume":"23","author":"T Ishiyama","year":"1987","unstructured":"Ishiyama T (1987) A case of aortitis syndrome complicated with IgA nephropathy presented with deposition of much collagen on glomeruli. Kidney Dialysis 23:937\u2013942 (Japanese)","journal-title":"Kidney Dialysis"},{"key":"5066_CR17","first-page":"295","volume":"20","author":"N Kobayashi","year":"1988","unstructured":"Kobayashi N (1988) A 16-year old girl of Takayasu disease complicated with IgA nephropathy. Jpn J Pediatr Med 20:295\u2013308 (Japanese)","journal-title":"Jpn J Pediatr Med"},{"key":"5066_CR18","unstructured":"Nemoto J (1992) A case of IgA nephropathy complicated with aortitis syndrome. In: The proceedings of regional meeting of the Japanese Society of Internal Medicine in Kanto district. vol  3, p 38 (Japanese)"},{"key":"5066_CR19","first-page":"25","volume":"48","author":"K Kanahara","year":"1999","unstructured":"Kanahara K, Yorioka N, Ogata S, Ohira N, Oobayashi M, Kiso T, Harada Y, Komiya H, Asakimori Y, Taniguchi Y, Yamakido M (1999) A case of aortitis syndrome and IgA nephropathy: possible role of human leukocyte antigens in both diseases. Hiroshima J Med Sci 48:25\u201329","journal-title":"Hiroshima J Med Sci"},{"key":"5066_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3165\/jjpn.19.25","volume":"19","author":"M Morimoto","year":"2006","unstructured":"Morimoto M, Sawai T, Kondo M, Horie T, Takeuchi Y, Nomura Y, Ohya N, Iwai M (2006) A case of Takayasu disease complicated with IgA nephropathy. Jpn J Pediatr Nephrol 19:25\u201330 (Japanese)","journal-title":"Jpn J Pediatr Nephrol"},{"key":"5066_CR21","first-page":"585","volume":"62","author":"E Okuyama","year":"2020","unstructured":"Okuyama E, Ichikawa D, Han W, Watanabe S, Sibasaki Y (2020) A case of Takayasu arteritis during therapy for IgA nephropathy. Jpn J Nephrol 62:585","journal-title":"Jpn J Nephrol"},{"key":"5066_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3760\/cma.j.issn.0578-1426.2018.02.009","volume":"57","author":"Z Chen","year":"2018","unstructured":"Chen Z, Yang YJ, Li J, Tian XP (2018) The clinical characteristics of Takayasu\u2019s arteritis with glomerulonephropathy. Zhonghua Nei Ke Za Zhi 57:129\u2013133. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2018.02.009 (Chinese)","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"5066_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s1001-9294(09)60063-8","volume":"24","author":"XM Li","year":"2009","unstructured":"Li XM, Ye WL, Wen YB, Li H, Chen LM, Liu DY, Zeng XJ, Li XW (2009) Glomerular disease associated with Takayasu arteritis: 6 cases analysis and review of the literature. Chin Med Sci J 24:69\u201375. https:\/\/doi.org\/10.1016\/s1001-9294(09)60063-8","journal-title":"Chin Med Sci J"},{"key":"5066_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000168824","volume":"15","author":"F Cavatorta","year":"1995","unstructured":"Cavatorta F, Campisi S, Trabassi E, Zollo A, Salvidio G (1995) IgA nephropathy associated with Takayasu\u2019s arteritis: report of a case and review of the literature. Am J Nephrol 15:165\u2013167. https:\/\/doi.org\/10.1159\/000168824","journal-title":"Am J Nephrol"},{"key":"5066_CR25","unstructured":"Japan Intractable Diseases Information Center (2021) IgA nephropathy. https:\/\/www.nanbyou.or.jp\/entry\/203. Accessed 6 Aug 2021 (Japanese)"},{"key":"5066_CR26","unstructured":"Japan Intractable Diseases Information Center (2021) Takayasu areteritis. https:\/\/www.nanbyou.or.jp\/entry\/290 Accessed 6 Aug 2021 (Japanese)"},{"key":"5066_CR27","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","volume":"289","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Raska M, Yamada K, Moldoveanu Z, Julian BA, Wyatt RJ, Tomino Y, Gharavi AG, Novak J (2014) Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem 289:5330\u20135339. https:\/\/doi.org\/10.1074\/jbc.M113.512277","journal-title":"J Biol Chem"},{"key":"5066_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","volume":"97","author":"Y Makita","year":"2020","unstructured":"Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y (2020) TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney Int 97:340\u2013349. https:\/\/doi.org\/10.1016\/j.kint.2019.08.022","journal-title":"Kidney Int"},{"key":"5066_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/MAJ.0b013e3181da4321","volume":"339","author":"A Komatsuda","year":"2010","unstructured":"Komatsuda A, Wakui H, Togashi M, Sawada K (2010) IgA nephropathy associated with castleman disease with cutaneous involvement. Am J Med Sci 339:486\u2013490. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181da4321","journal-title":"Am J Med Sci"},{"key":"5066_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/01.cir.100.1.55","volume":"100","author":"M Noris","year":"1999","unstructured":"Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G (1999) Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 100:55\u201360. https:\/\/doi.org\/10.1161\/01.cir.100.1.55","journal-title":"Circulation"},{"key":"5066_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03009742.2021.1881155","volume":"17","author":"T Shirai","year":"2021","unstructured":"Shirai T, Sato H, Fujii H, Ishii T, Harigae H (2021) The feasible maintenance dose of corticosteroid in Takayasu arteritis in the era of biologic therapy. Scand J Rheumatol 17:1\u20137. https:\/\/doi.org\/10.1080\/03009742.2021.1881155","journal-title":"Scand J Rheumatol"},{"key":"5066_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3899\/jrheum.181219","volume":"47","author":"T Mutoh","year":"2020","unstructured":"Mutoh T, Shirai T, Fujii H, Ishii T, Harigae H (2020) Insufficient use of corticosteroids without immunosuppressants results in higher relapse rates in Takayasu arteritis. J Rheumatol 47:255\u2013263. https:\/\/doi.org\/10.3899\/jrheum.181219","journal-title":"J Rheumatol"},{"key":"5066_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.autrev.2011.11.025","volume":"11","author":"C Comarmond","year":"2012","unstructured":"Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z, Cacoub P, Saadoun D (2012) Anti TNF-\u03b1 in refractory Takayasu\u2019s arteritis: cases series and review of the literature. Autoimmun Rev 11:678\u2013684. https:\/\/doi.org\/10.1016\/j.autrev.2011.11.025","journal-title":"Autoimmun Rev"},{"key":"5066_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mehy.2017.07.016","volume":"107","author":"V Di Lernia","year":"2017","unstructured":"Di Lernia V (2017) IgA nephropathy during treatment with TNF-alpha blockers: could it be predicted? Med Hypotheses 107:12\u201313. https:\/\/doi.org\/10.1016\/j.mehy.2017.07.016","journal-title":"Med Hypotheses"},{"key":"5066_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jbspin.2012.07.015","volume":"80","author":"N Mariani","year":"2013","unstructured":"Mariani N, So A, Aubry-Rozier B (2013) Two cases of Takayasu\u2019s arteritis occurring under anti-TNF therapy. Jt Bone Spine 80:211\u2013213. https:\/\/doi.org\/10.1016\/j.jbspin.2012.07.015","journal-title":"Jt Bone Spine"},{"key":"5066_CR36","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2169\/internalmedicine.4331-19","volume":"59","author":"T Shirai","year":"2020","unstructured":"Shirai T, Komatsu H, Sato H, Fujii H, Ishii T, Harigae H (2020) Migratory aortitis associated with granulocyte-colony-stimulating factor. Intern Med 59:1559\u20131563. https:\/\/doi.org\/10.2169\/internalmedicine.4331-19","journal-title":"Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-05066-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T08:05:42Z","timestamp":1675411542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-05066-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["5066"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-05066-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the Tohoku University Graduate School of Medicine (approval number, 10788).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for publication of this letter was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}